Æó±âÁ¾ Ä¡·á ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Ä¡·áº°, À¯Åë ä³Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÎ¹®, °æÀï(2020-2030³â)
Emphysema Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment, By Distribution Channel, By End-User, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1691726
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Æó±âÁ¾ Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 44¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È 63¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2030³â±îÁö 6.02%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è Æó±âÁ¾ Ä¡·á ½ÃÀåÀº ÀÇ·á±â¼úÀÇ ¹ßÀü°ú ¸¸¼º È£Èí±â Áúȯ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Æó±âÁ¾Àº Èí¿¬ ¹× ȯ°æ ¿À¿° ¹°Áú°ú °ü·ÃÀÌ ÀÖ´Â ÁøÇ༺ ÆóÁúȯÀ¸·Î, À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾à»ç ¹× ÀÇ·á±â±â ¾÷üµéÀº Áö¼Ó¼º ±â°üÁö È®ÀåÁ¦, »ý¹°ÇÐÀû Á¦Á¦, ÆóȰ·® °¨¼Ò ¼ö¼ú(LVRS) ¹× ±â°üÁö ³» ÆÇ¸· À̽ļú°ú °°Àº ÃÖ¼Ò Ä§½ÀÀû ¼ö¼ú µî Çõ½ÅÀûÀÎ Ä¡·á¹ý °³¹ß¿¡ Àû±Ø ³ª¼­°í ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü Ä¡·á Àü·«À¸·ÎÀÇ ÀüȯÀº Áúº´ÀÇ ÁßÁõµµ ¹× Ä¡·á¿¡ ´ëÇÑ °³º° ¹ÝÀÀ¿¡ µû¶ó °³ÀÔÀ» Á¶Á¤ÇÔÀ¸·Î½á ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë »ê¼ÒÄ¡·á±â ¹× µðÁöÅРȣÈí ¸ð´ÏÅ͸µ µµ±¸¿Í °°Àº Ȩ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ È®´ë´Â Áúº´ °ü¸®¸¦ °­È­ÇÏ¿© ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 44¾ï 7,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 63¾ï 6,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 6.02%
±Þ¼ºÀå ºÎ¹® ¿Ü·¡¼ö¼ú¼¾ÅÍ
ÃÖ´ë ½ÃÀå ºÏ¹Ì

Àç»ýÀÇ·á¿Í À¯ÀüÀÚ ±â¹Ý Ä¡·á¹ý ¿¬±¸°¡ ÁøÇàµÇ¸é¼­ Áúº´ º¯ÇüÀÇ °¡´É¼ºÀ» ¸ð»öÇÏ´Â µî Ä¡·áÀÇ Àü¸ÁÀÌ ¹Ù²î°í ÀÖ½À´Ï´Ù. Ç¥ÀûÈ­µÈ Ç׿°Áõ ¹× Àç»ý Ä¡·áÁ¦ÀÇ °³¹ßÀº Áúº´ÀÇ ÁøÇàÀ» ´ÊÃß°í Æó ±â´ÉÀ» °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À Á¦¾à»çµéÀº »õ·Î¿î Ä¡·á ¼ö´ÜÀ¸·Î ´ÜŬ·Ð Ç×ü¿Í Áٱ⼼Æ÷ ¿ä¹ý¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. Áø´Ü°ú Áúº´ ¸ð´ÏÅ͸µ¿¡ ÀΰøÁö´É(AI)À» ÅëÇÕÇϸé Á¶±â ¹ß°ß°ú º¸´Ù Á¤È®ÇÑ °³ÀÔÀÌ °¡´ÉÇØÁ® ÇÕº´ÁõÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â Ä¡·á È¿°ú Çâ»ó°ú ºÎÀÛ¿ë °¨¼Ò¿¡ ÁßÁ¡À» µÎ°í Á¦ÈÞ ¹× ÀÓ»ó½ÃÇèÀ» ÅëÇØ ÆÄÀÌÇÁ¶óÀÎÀ» È®ÀåÇÏ´Â µ¥ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±â°üÁö È®ÀåÁ¦, Ç׿°ÁõÁ¦, Æó ÀçȰ ÇÁ·Î±×·¥À» ÅëÇÕÇÑ º´¿ë¿ä¹ýÀÌ °­Á¶µÇ°í, Á¾ÇÕÀûÀÎ Áúº´ °ü¸®°¡ °­È­µÇ°í, Á¦Ç° Çõ½ÅÀÌ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

ÀÇ·á±â¼úÀÇ ¹ßÀü

ÁÖ¿ä ½ÃÀå À̽´

³ôÀº Ä¡·áºñ

ÁÖ¿ä ½ÃÀå µ¿Çâ

ÃÖ¼Òħ½À ¼ö¼úÀÇ Ã¤ÅÃ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°èÀÇ Æó±âÁ¾ Ä¡·á ½ÃÀå Àü¸Á

Á¦5Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Æó±âÁ¾ Ä¡·á ½ÃÀå Àü¸Á

Á¦6Àå À¯·´ÀÇ Æó±âÁ¾ Ä¡·á ½ÃÀå Àü¸Á

Á¦7Àå ºÏ¹ÌÀÇ Æó±âÁ¾ Ä¡·á ½ÃÀå Àü¸Á

Á¦8Àå ³²¹ÌÀÇ Æó±âÁ¾ Ä¡·á ½ÃÀå Àü¸Á

Á¦9Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Æó±âÁ¾ Ä¡·á ½ÃÀå Àü¸Á

Á¦10Àå ½ÃÀå ¿ªÇÐ

Á¦11Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦12Àå ¼¼°èÀÇ Æó±âÁ¾ Ä¡·á ½ÃÀå : SWOT ºÐ¼®

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ¸®¼­Ä¡»ç¿¡ ´ëÇØ & ¸éÃ¥»çÇ×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Emphysema Treatment Market was valued at USD 4.47 Billion in 2024 and is expected to reach USD 6.36 Billion in the forecast period with a CAGR of 6.02% through 2030. The global emphysema treatment market is witnessing steady growth, driven by advancements in medical technology and increasing awareness about chronic respiratory diseases. Emphysema, a progressive lung condition often linked to smoking and environmental pollutants, has seen a rise in prevalence, prompting demand for effective treatment options. Pharmaceutical and medical device companies are actively developing innovative therapies, including long-acting bronchodilators, biologics, and minimally invasive procedures like lung volume reduction surgery (LVRS) and endobronchial valve implantation. The shift toward personalized treatment strategies is improving patient outcomes by tailoring interventions based on disease severity and individual response to therapy. The expansion of home healthcare solutions, including portable oxygen therapy devices and digital respiratory monitoring tools, is enhancing disease management and supporting market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.47 Billion
Market Size 2030USD 6.36 Billion
CAGR 2025-20306.02%
Fastest Growing SegmentAmbulatory Surgical Centers
Largest MarketNorth America

Ongoing research into regenerative medicine and gene-based therapies is transforming the treatment landscape by exploring potential disease-modifying solutions. The development of targeted anti-inflammatory and regenerative therapies aims to slow disease progression and improve lung function. Biopharmaceutical companies are focusing on monoclonal antibodies and stem cell therapies as emerging treatment avenues. The integration of artificial intelligence (AI) in diagnostics and disease monitoring is enabling early detection and more precise intervention, reducing complications. Companies are investing in pipeline expansion through collaborations and clinical trials, with an emphasis on improving treatment efficacy and reducing adverse effects. The emphasis on combination therapies, incorporating bronchodilators, anti-inflammatory drugs, and pulmonary rehabilitation programs, is enhancing comprehensive disease management and driving product innovation.

Key Market Drivers

Advancements in Medical Technology

Advancements in medical technology are significantly enhancing the global emphysema treatment market. Emphysema, a debilitating form of chronic obstructive pulmonary disease (COPD), has historically been challenging to manage. However, recent technological breakthroughs are transforming emphysema care.

Minimally invasive procedures, such as bronchoscopic lung volume reduction (BLVR), have become pivotal in emphysema treatment. BLVR involves the insertion of devices like endobronchial valves to occlude diseased lung regions, thereby improving respiratory function. Clinical studies have demonstrated that BLVR can enhance lung performance and quality of life in selected patients. For instance, research indicates that BLVR procedures have shown promising outcomes in improving lung function and exercise capacity among patients with advanced emphysema.

The development of biologics and targeted therapies marks another significant advancement in emphysema management. These treatments aim at specific molecular pathways that contribute to disease progression, potentially decelerating emphysema's advancement and enhancing pulmonary function. This targeted approach offers a more effective and less invasive alternative to traditional therapies.

Key Market Challenges

High Treatment Costs

High treatment costs are a significant barrier hindering the advancement of the Global Emphysema Treatment Market. Emphysema, a debilitating chronic obstructive pulmonary disease (COPD), affects millions of individuals worldwide, and managing this condition can be financially burdensome for both patients and healthcare systems.

The development of innovative emphysema treatments, such as bronchoscopic lung volume reduction (BLVR) procedures and targeted biologics, has offered new hope to patients by providing potentially more effective and less invasive options. However, these cutting-edge treatments often come with a hefty price tag.

For many emphysema patients, the high cost of treatment represents a substantial financial barrier. Coping with the financial burden of these therapies can be overwhelming, particularly for those without comprehensive health insurance coverage. High deductibles, copayments, and out-of-pocket expenses can strain patients' finances and limit their access to essential treatments.

Additionally, emphysema is a chronic condition that often requires ongoing care, including medications, regular check-ups, and pulmonary rehabilitation. These long-term expenses further compound the financial challenges faced by patients, potentially forcing them to make difficult choices between healthcare and other essential needs.

The burden of high treatment costs also extends to healthcare systems and governments. As the prevalence of emphysema continues to rise, the strain on healthcare budgets becomes more pronounced. The cost of providing advanced treatments and therapies can lead to allocation challenges, diverting resources from other critical healthcare needs.

Key Market Trends

Adoption of Minimally Invasive Procedures

The adoption of minimally invasive procedures is playing a pivotal role in boosting the Global Emphysema Treatment Market. Emphysema, a progressive lung condition characterized by the destruction of lung tissue, has traditionally been associated with invasive surgical treatments or long-term medication. However, recent advancements in medical technology have led to the development and widespread adoption of minimally invasive procedures, offering a paradigm shift in the way emphysema is treated.

One of the most significant contributors to the growth of minimally invasive procedures is the emergence of bronchoscopic lung volume reduction (BLVR) techniques. BLVR involves the insertion of small devices or materials into the airways to block or reduce airflow to damaged lung areas. This procedure aims to improve lung function and alleviate symptoms without the need for open surgery. Patients benefit from shorter hospital stays, faster recovery times, and reduced risk of complications compared to traditional surgical approaches.

The appeal of minimally invasive procedures goes beyond their effectiveness; it lies in their patient-centric approach. Patients are more inclined to opt for less invasive treatments that offer quicker recovery times and a lower risk of complications. As a result, healthcare providers increasingly recommend and perform BLVR and other minimally invasive procedures, meeting the preferences and expectations of patients.

Moreover, the adoption of minimally invasive procedures aligns with the broader trend in healthcare toward value-based care and cost-effectiveness. These procedures typically lead to reduced healthcare costs due to shorter hospital stays and less post-operative care, benefiting both patients and healthcare systems.

Key Market Players

Report Scope:

In this report, the Global Emphysema Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Emphysema Treatment Market, By Treatment:

Emphysema Treatment Market, By Distribution Channel:

Emphysema Treatment Market, By End-User:

Emphysema Treatment Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Emphysema Treatment Market.

Available Customizations:

Global Emphysema Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Emphysema Treatment Market Outlook

5. Asia Pacific Emphysema Treatment Market Outlook

6. Europe Emphysema Treatment Market Outlook

7. North America Emphysema Treatment Market Outlook

8. South America Emphysema Treatment Market Outlook

9. Middle East and Africa Emphysema Treatment Market Outlook

10. Market Dynamics

11. Market Trends & Developments

12. Global Emphysema Treatment Market: SWOT Analysis

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â